Outcomes in Four Children with Persistent, Recurrent, and Progressive Gangliogliomas Treated in Phase II Studies with Antineoplastons A10 and AS2-1
Burzynski Stanislaw, Burzynski Gregory, Janicki Tomasz, Beenken Samuel
Rec. Date:
2022-09-01
Acc. Date:
2022-09-06
Pub. Date:
2022-09-10
